Safety, tolerability, pharmacokinetics, and effects on human experimental pain of the selective ionotropic glutamate receptor 5 (iGluR5) antagonist LY545694 in healthy volunteers

In a 2-part study in healthy volunteers, we first established a maximally tolerated multiple dose of LY545694 of 25mg twice daily and subsequently demonstrated antihyperalgesic effect using effects in the brief thermal stimulation experimental pain model. The antihyperalgesic effect was similar to t...

Full description

Saved in:
Bibliographic Details
Published inPain (Amsterdam) Vol. 155; no. 5; pp. 929 - 936
Main Authors Petersen, Karin L., Iyengar, Smriti, Chappell, Amy S., Lobo, Evelyn D., Reda, Haatem, Prucka, William R., Verfaille, Steven J.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Elsevier B.V 01.05.2014
International Association for the Study of Pain
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…